PASIREOTIDE subcutaneous injection (Signifor®)

Clinical Indication

Cushing’s disease

Comments

Not yet reviewed

Date of classification

March 2016

Review date

March 2016

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.